John Aballi

Insider Reports History

Entity
Individual
Location
C/O Decipher Biosciences, Inc., 6925 Lusk Blvd, Suite 200, San Diego, CA
Signature
/s/ Jeffrey G. Black, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Aballi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
EXAGEN INC. President and CEO, Director Common Stock 746K $1.84M $2.47 Feb 28, 2025 Direct
EXAGEN INC. President and CEO, Director Stock Option(right to buy) 75K $269K $3.58 Feb 21, 2025 Direct
EXAGEN INC. President and CEO, Director Common Stock 40.4K $99.6K $2.47 Feb 28, 2025 by Spouse

Insider Reports Filed by John Aballi

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XGN EXAGEN INC. Feb 28, 2025 1 $21.3K 4 Mar 4, 2025 President and CEO, Director
XGN EXAGEN INC. Feb 21, 2025 2 $269K 4 Feb 25, 2025 President and CEO, Director
XGN EXAGEN INC. Nov 14, 2024 0 $0 4/A Feb 25, 2025 President and CEO, Director
XGN EXAGEN INC. May 16, 2024 1 $77.6K 4 May 16, 2024 President and CEO, Director
XGN EXAGEN INC. Feb 29, 2024 1 $18.7K 4 Mar 4, 2024 President and CEO, Director
XGN EXAGEN INC. Feb 20, 2024 1 $0 4 Feb 22, 2024 President and CEO, Director
XGN EXAGEN INC. Oct 17, 2023 1 -$59K 4 Oct 18, 2023 President and CEO, Director
XGN EXAGEN INC. Aug 31, 2023 1 $21K 4 Sep 6, 2023 President and CEO, Director
XGN EXAGEN INC. Dec 8, 2022 1 $241K 4 Dec 9, 2022 President and CEO, Director
XGN EXAGEN INC. Oct 16, 2022 1 $0 4 Oct 18, 2022 President and CEO, Director
XGN EXAGEN INC. Oct 16, 2022 0 $0 3 Oct 18, 2022 President and CEO, Director